Coenzyme Q-10
- SCIENTIFIC NAMES: Mitoquinone; Ubidecarenone; Ubiquinone
- INDICATIONS: Congestive heart failure, angina, diabetes, hypertension, breast cancer, increasing exercise tolerance, muscular dystrophy, chronic fatigue
- SYNONYM: None
- CLASS: Food supplement
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
CoQ-10 was first identified in 1957. It is widely used in Japan where millions of Japanese patients receive CoQ-10 as part of their treatment for congestive heart failure.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric